3[1]Aarsman AJ,Ransohoff J,Hunt WE et al.Lipocrtin inhibition of extracelluar and intracelluar phospholipase A2 is substrate concentration dependent[H].FEBS Lett,1987,219:176-180.
4[2]Anderson DK,Braughler JM,Hall ED et al.Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury[J].J Neurosurg,1988,69:562-567.
5[3]Anderson DK:Iron-induced lipid peroxidation in spinal cord:protection with mannitol and methylprednisolone[J].J Free Radic Biol Med.1985,1:59-64.
6[4]Anderson DK,Means ED.Lipid hydrolysis and peroxidation in injuried spinalcord:portial protection with methylprednisolone or vitamine E and slenium[J].Cent Nero Syst Trauma,1985,2:257-267.
7[5]Anderson DK,Means ED,Waters TR et al.Microvascular perfusion and metalolism in injured spinal cord after methylprednisolone treatment[J].J Neurosurg,1982,56:106-113.
8[6]Andrew CB,Myers RA,Ducker TB.Molecular mechanisms of anti-inflammatory action of glucocorticoids[J].Bio Essays,1996,18:371-378.
9[7]Behrmann DL,Bresnahan JC,Beattie MS.Modeling of acute spinal cord injury in the rat:neuro-protection and enhanced recovery with methylprednisolone,U-74006F and YM-14673[J].Experimental Neurology,1994,126:61-75.
10[8]Bracken MB,Shepard MJ,COllins WF,et al.A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury[J].The New England J of Medicine.1990,322:1405-1411.
